ProfileGDS4718 / 36920_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 89% 71% 93% 95% 75% 74% 89% 94% 92% 94% 93% 83% 82% 86% 89% 94% 80% 67% 58% 93% 93% 95% 92% 92% 78% 91% 75% 90% 84% 83% 68% 90% 92% 74% 82% 84% 88% 90% 74% 91% 79% 81% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.274690
GSM549102patient 115, normal, homogenized [OPG study]9.0202589
GSM549104patient 119, normal, homogenized [OPG study]6.9712571
GSM549108patient 138, normal, homogenized [OPG study]9.6095793
GSM549119patient 077, normal, homogenized [OPG study]10.297995
GSM549133patient 032, cancer, homogenized [OPG study]7.4640175
GSM549139patient 042, cancer, homogenized [OPG study]7.2792974
GSM549099patient 107, normal, homogenized [OPG study]8.9335789
GSM549109patient 139, normal, homogenized [OPG study]9.9537494
GSM549110patient 046, normal, homogenized [OPG study]9.6891492
GSM549114patient 063, normal, homogenized [OPG study]10.106694
GSM549122patient 082, normal, homogenized [OPG study]9.7392393
GSM549134patient 033, cancer, homogenized [OPG study]8.2517683
GSM549136patient 036, cancer, homogenized [OPG study]8.1737982
GSM549140patient 044, cancer, homogenized [OPG study]8.6925886
GSM549111patient 047, normal, homogenized [OPG study]9.0411789
GSM549113patient 057, normal, homogenized [OPG study]10.19194
GSM549132patient 031, cancer, homogenized [OPG study]7.8239880
GSM549137patient 038, cancer, homogenized [OPG study]6.6873367
GSM549142patient 047, cancer, homogenized [OPG study]6.0830758
GSM549100patient 110, normal, homogenized [OPG study]9.7163893
GSM549107patient 135, normal, homogenized [OPG study]9.7972793
GSM549115patient 068, normal, homogenized [OPG study]10.419595
GSM549116patient 072, normal, homogenized [OPG study]9.72492
GSM549120patient 078, normal, homogenized [OPG study]9.6667892
GSM549131patient 030, cancer, homogenized [OPG study]7.7862578
GSM549118patient 074, normal, homogenized [OPG study]9.423691
GSM549129patient 027, cancer, homogenized [OPG study]7.4153675
GSM549123patient 088, normal, homogenized [OPG study]9.2151890
GSM549124patient 006, cancer, homogenized [OPG study]8.2720884
GSM549126patient 015, cancer, homogenized [OPG study]8.1750983
GSM549128patient 025, cancer, homogenized [OPG study]6.7544668
GSM549103patient 117, normal, homogenized [OPG study]9.0426990
GSM549117patient 073, normal, homogenized [OPG study]9.7818492
GSM549138patient 041, cancer, homogenized [OPG study]7.2369374
GSM549141patient 045, cancer, homogenized [OPG study]8.248182
GSM549130patient 028, cancer, homogenized [OPG study]8.3040884
GSM549101patient 111, normal, homogenized [OPG study]8.7635988
GSM549105patient 128, normal, homogenized [OPG study]9.2290390
GSM549106patient 134, normal, homogenized [OPG study]7.4012174
GSM549112patient 048, normal, homogenized [OPG study]9.3899691
GSM549125patient 011, cancer, homogenized [OPG study]7.6741579
GSM549127patient 024, cancer, homogenized [OPG study]8.0309981
GSM549135patient 035, cancer, homogenized [OPG study]7.7002578